BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Transatlantic Trade & Investment Partnership (TTIP) - Proposed Free Trade Agreement between the European Union and the United States (Market Access; Industry-Specific Regulation; Broader Rules and Principles and Modes of Co-operation); TPA, TTP.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA PORTER TEMME | — |
Health Issues HCR
Cost Sharing (Preserving Access to Medicines); HR 9 - Patent Bill; Healthcare Exchanges; HR 2985 Combined Drug Development Incentive Act; HR 3116 Modernizing our Drug & Diagnostic Evaluation & Regulatory Network; S-1137 Patent Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DORST New | — |
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| ALANNA PORTER TEMME | — |
Medicare/Medicaid MMM
Average Sales Price; Reimbursement; Medicare Sustainable Growth Rate Bill HR 2 and Children Health Insurance Program Act of 2015; 21st Century Cures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DORST New | — |
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| ALANNA PORTER TEMME | — |
Budget/Appropriations BUD
House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Importation; Non Interference.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DORST New | — |
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| ALANNA PORTER TEMME | — |
Consumer Issues/Safety/Products CSP
Food and Drug Administration Safety & Innovation Act (FDASIA) [Implementation]; 21st Century Cures Proposal.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN DORST New | — |
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| ALANNA PORTER TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.